Company Description
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally.
The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments.
It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease.
The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities.
In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform.
Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles.
The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024.
Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
Country | Israel |
Founded | 1999 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 84 |
CEO | Liron Carmel |
Contact Details
Address: 10 Hanechoshet, 4th Floor Tel Aviv, 6971072 Israel | |
Website | medigus.com |
Stock Details
Ticker Symbol | XYLO |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001618500 |
ISIN Number | US58471G4091 |
SIC Code | 7374 |
Key Executives
Name | Position |
---|---|
Liron Carmel | Chief Executive Officer |
Tali Dinar | Chief Financial Officer |
Ilan Oren | Executive Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 15, 2024 | 424B5 | Filing |
Nov 15, 2024 | 6-K | Report of foreign issuer |
Oct 31, 2024 | 6-K | Report of foreign issuer |
Sep 25, 2024 | 6-K | Report of foreign issuer |
Sep 20, 2024 | 6-K | Report of foreign issuer |
Aug 15, 2024 | 6-K | Report of foreign issuer |
Aug 14, 2024 | 6-K | Report of foreign issuer |
Jul 30, 2024 | 6-K | Report of foreign issuer |
Jul 22, 2024 | 424B3 | Prospectus |
Jun 7, 2024 | 144 | Filing |